Abstracts should be submitted in English only.
The success of any scientific meeting depends upon the quality of not only its plenary lectures, but also the free communications contributed by the registrants. Consequently, much thought has been devoted to ensuring that our meeting will provide the best possible forum for registrants to present their new and exciting research and clinical results.
As with every meeting there is a finite amount of time that can be dedicated in the program for presentation of oral free communications and many registrants’ work has to be assigned to poster presentations. Abstracts will be subject to anonymous peer review by 3 or more referees and, in general, those with the highest scores will be assigned oral presentation format.
Other accepted abstracts will be assigned to poster format presentation. If you are not willing to accept either an oral or a poster format presentation, you must indicate this at the time of submission. For Poster presentation guidelines please click here.
Any topic relevant to human reproduction, assisted conception or reproductive genetics will be considered for inclusion in the meeting program. Abstracts must report results of a study or investigation. Any abstract not including adequate data, or saying that “results will be presented / discussed” will not be accepted. Appropriate statistical analysis of data must be presented.
Material submitted should not have been presented at a national or international meeting or published prior to our meeting.
By submitting an abstract, authors warrant that the work was conducted in complete accordance with any and all local, national and international ethical guidelines or regulations, including the Nuremberg Code and the Declaration of Helsinki.
To view a sample abstract please click here.
Use a structured layout for the abstract including headings (in bold): Introduction, Materials and Methods, Results, Discussion (or Conclusions), and References (if applicable).
Authorship of abstracts should conform to international standards. Read more »»
The abstract should be typed single-spaced with one line of space between paragraphs and headings. Do not indent paragraphs.
The body of the document should be no more than 375 words (2200 characters, including spaces).
Please make sure that the abstract file document is in .doc or .docx format.
Introduction - should be informative and short, stating why the study was conducted.
Material & methods - indicating the locale, number and type of human subjects, non-human species or material being studied, the principal procedures, assays, tests or treatments performed.
Results - confirming or refuting the hypothesis, supported by statistics if appropriate.
Conclusions - stating the major new findings of the study and specifying what these findings add to what is known already.
References - if applicable.
Type the title in bold, authors in italics, and body in normal text.
Do not use capital letters and do not indent.
The title should reflect the contents and should be no longer than 150 characters.
List all authors first name followed by family name followed by affiliation.
(i.e. John Campbell1, Margaret Witherspoon2;
1 University of Toronto, Ontario, Canada, 2 Fertility Clinic, Red Deer, Alberta, Canada)
The name of the first author is also the presenting author.
Do not include professional titles or degrees.
Graphic elements such as tables and graphs should be included in your document. However, please DO NOT incorporate any large graphic elements, as this will limit the amount of words you may include.
As a guide, all text and graphics must fit within a 7.5" by 8" box.
Abbreviations, acronyms and units:
Standard abbreviations and acronyms may be used without prior definition (e.g. IVF, OPU, GnRH, FSH, HSA, etc), but all non-standard terms must be defined where first used in the text.
SI units should be used throughout.
Identify significant differences using an italic capital letter “P”, e.g. P
Please check your abstract carefully; it will be published as submitted.
An Ethical Standards Disclosure Form for the presenter and EACH author must be completed for each submitted abstract.
All abstracts will be evaluated blindly by the Program Committee.
You will be notified by email by the end of May 2013 as to whether or not your abstract has been accepted for presentation and you will be provided with details regarding designation (i.e., oral or poster), classification, and time allocation.
Only registered meeting participants will be accepted as abstract presenters. Submission of an abstract indicates acceptance of and compliance with the abstract submission guidelines.
Abstract will NOT be included in the program unless the presenting author register for the meeting
no later than June 15, 2013
HARD COPY ABSTRACTS (SENT BY FAX OR MAIL) WILL BE DISCARDED!!!
Please read the instructions carefully and follow the steps for submission. For each step, make sure that all required fields are completed before moving on to the next step.